Connection

Laure Gossec to Minimal Clinically Important Difference

Back to Details
This is a "connection" page, showing publications Laure Gossec has written about Minimal Clinically Important Difference.
Laure Gossec
Connection Strength
0.235
Minimal Clinically Important Difference
  1. An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS. Ann Rheum Dis. 2018 Jan; 77(1):124-127.
    View in: PubMed
    Score: 0.180
  2. Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR). Rheumatology (Oxford). 2020 07 01; 59(7):1495-1504.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.